These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Therapeutic effect of sorafenib on portal hypertension: research progress and mechanisms]. Zhu Y; Cheng Y; Li A; Luo R Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):133-6. PubMed ID: 24463135 [TBL] [Abstract][Full Text] [Related]
6. Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension. García-Pagán JC; Escorsell A; Moitinho E; Bosch J Semin Liver Dis; 1999; 19(4):427-38. PubMed ID: 10643627 [TBL] [Abstract][Full Text] [Related]
7. Portal pressure response to propranolol in portal hypertension. Ozsoylu S; Koçak N; Yüce A; Ozbag E J Hepatol; 1992 May; 15(1-2):270-1. PubMed ID: 1506652 [No Abstract] [Full Text] [Related]
8. Metformin for castrate-resistant prostate cancer: learning more about an old dog's new tricks. Hamilton RJ Eur Urol; 2014 Sep; 66(3):475-7; discussion 477-8. PubMed ID: 24472709 [No Abstract] [Full Text] [Related]
9. Statins and portal hypertension: a new pharmacological challenge. Ramírez G; Briceño J; Rojas A Curr Vasc Pharmacol; 2012 Nov; 10(6):767-72. PubMed ID: 22272892 [TBL] [Abstract][Full Text] [Related]
10. Review article: the pathophysiology and pharmacological treatment of portal hypertension. Grose RD; Hayes PC Aliment Pharmacol Ther; 1992 Oct; 6(5):521-40. PubMed ID: 1420745 [TBL] [Abstract][Full Text] [Related]
12. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding. Lebrec D Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension. Jenkins SA; Shields R J Gastroenterol Hepatol; 1991; 6(1):91-3. PubMed ID: 1883984 [No Abstract] [Full Text] [Related]
14. Beta blockers in portal hypertension--current status. Koshy A Trop Gastroenterol; 1989; 10(3):142-7. PubMed ID: 2573188 [TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic targets for prevention of portal-systemic collaterals in portal hypertension. Ling SC J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):121-2. PubMed ID: 16385272 [No Abstract] [Full Text] [Related]
16. [Current status and prospects of integrated traditional Chinese and Western medicine for treatment of portal hypertension]. Wang J; Zhu XN; Zhang YR; Gao YQ; Yang YP Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):249-253. PubMed ID: 29996333 [TBL] [Abstract][Full Text] [Related]
17. Drug therapy of portal hypertension. Groszmann RJ Am J Gastroenterol; 1987 Feb; 82(2):107-13. PubMed ID: 3544812 [TBL] [Abstract][Full Text] [Related]
18. [Beta-blockers and portal hypertension: in search of the ideal]. Bandi JC; Mastai R Acta Gastroenterol Latinoam; 1998; 28(4):313-4. PubMed ID: 10347688 [No Abstract] [Full Text] [Related]